StockData
PENNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

Penumbra Inc

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$322.41+1.55 (+0.48%)

Close on Oct 19, 2026

Market cap
$12.76B
P/E (TTM)
79.2
Dividend yield
–

Penumbra Inc balance sheet

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
67.8%
Operating margin
12.4%
Net margin
10.7%
Return on equity, FY2025
13.8%

Financial strength

Current ratio
5.75
Debt to equity
–
Debt to assets
–
Cash to current liabilities
87.8%

Valuation

P/E ratio
79.2
Price to sales
8.48
Price to book
8.33
Dividend yield
–